Pounce™ Thrombectomy System Retrospective Registry

Restoration of pulsatile flow in the target lesion(s) with or without adjunctive treatment as determined by the core lab and physician

Death, Unplanned major amputation (above ankle), Clinically Driven target lesion revascularization (TLR)

Restoration of blood flow to the target lesion(s) with <50% residual thrombus without the need to initiate CDT or to proceed to open surgery or other endovascular thrombectomy device as determined by the core lab

Completeness of thromboemboli removal (by angiography) not including underlying atheroma as determined by the core lab and physician

TIPI flow rate at the end of thrombectomy procedure and after any adjunctive procedures as determined by the core lab and physician.

Pre-procedure vs. post-procedure runoff using a modified SVS runoff score as determined by the core lab and physician (if applicable).

Length of underlying atheroma stenosis necessitating treatment compared to original lesion length as determined by the core lab and physician

Number of passes of Pounce Thrombectomy System

• Total number of passes
• Number of passes in each vessel

Percentage of subjects in whom adjunctive procedures were performed

▪ Treatment for: underlying atheroma, residual thrombus, residual embolus, other

Total procedure duration (minutes) Duration of Pounce Thrombectomy System use (minutes)

Length of stay

Time from end of procedure to discharge

Incidence of same day discharge

Incidence of next day discharge

Incidence of ICU admission

Duration of ICU admission

Determined by the investigator using DUS or ABI

Improvement by at least one class at 30 days as compared to procedure

Characterize Rutherford classification

Change in ABI at 30 days compared to baseline.

Major bleeding (requiring transfusion) Arterial perforation Flow-limiting dissection (at the end of the procedure, prior to and following stenting, if performed) Distal embolization requiring surgical procedure or obstructing one of the major downstream vessels >70% (at the end of the procedure)

Infection (requiring IV antibiotics or surgical treatment) Pseudoaneurysm (requiring surgical or endovascular treatment) Seroma (requiring surgical treatment) Other access site related AEs

• Numbness
• Other